Model
Edge
Jazz Pharmaceuticals
JAZZ
Filing Type
10-K
Filing Date
2/23/2026
Updated
2/24/26, 2:10 PM
Filing
10-K
Earnings Release
Exhibits
10-K
FY 2024
EX-4.1
DESCRIPTION OF SHARE CAPITAL
EX-19.1
INSIDER TRADING POLICY
EX-21.1
LIST OF SUBSIDIARIES
EX-23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-31.1
CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)
EX-31.2
CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)
EX-32.1
CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350
GRAPHIC
Graphic
GRAPHIC
Graphic